Meredith Manning joined PharmaEssentia in 2020 as their U.S. General Manager, and in 2022 became President, The Americas. She has over two decades of experience commercializing biopharmaceuticals and medical devices, and previously served as Chief Commercial Officer at resTORbio and as an independent consultant partnering with pharmaceutical and biotechnology clients in developing and executing growth, launch, and competitive defense strategies with a focus on marketing, sales and business development opportunities.
Prior to this, Meredith served as Vice President, Global Product Strategy Lead Hemophilia at Shire and as Vice President, Global Hemophilia Marketing at Baxalta. She was the Senior Director and Vice President, Global Hemophilia Marketing at Baxter International as well. Meredith began her career with a seven-year stint at Pfizer as a Director, Marketing, followed by a number of years as the Senior Director, Marketing at Vertex Pharmaceuticals.
She received a B.A. in Political Science and Government from Colorado College, and an I.M.B.A at the University of Chicago Booth School of Business.
Prior to this, Meredith served as Vice President, Global Product Strategy Lead Hemophilia at Shire and as Vice President, Global Hemophilia Marketing at Baxalta. She was the Senior Director and Vice President, Global Hemophilia Marketing at Baxter International as well. Meredith began her career with a seven-year stint at Pfizer as a Director, Marketing, followed by a number of years as the Senior Director, Marketing at Vertex Pharmaceuticals.
She received a B.A. in Political Science and Government from Colorado College, and an I.M.B.A at the University of Chicago Booth School of Business.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5
